RmtC 16S rRNA Methyltransferase in Australia
Copyright policy )RmtC 16S rRNA Methyltransferase in Australia
Proteus mirabilis isolate JIE273 was recovered in March 2007 from the urine of an inpatient at Blacktown Hospital, Sydney. In vitro susceptibility tests (Phoenix NMIC/ID-101 panel; BD, Franklin Lakes, NJ) indicated that JIE273 was susceptible to imipenem (MIC, ≤2 μg/ml), cefoxitin (MIC, ≤4 μg/
- University of Sydney Australia
- Westmead Hospital Australia
Australia, Genes, rRNA, Methyltransferases, Microbial Sensitivity Tests, beta-Lactams, beta-Lactam Resistance, beta-Lactamases, Anti-Bacterial Agents, Aminoglycosides, RNA, Ribosomal, 16S, Drug Resistance, Bacterial, Humans, Proteus Infections, Proteus mirabilis
Australia, Genes, rRNA, Methyltransferases, Microbial Sensitivity Tests, beta-Lactams, beta-Lactam Resistance, beta-Lactamases, Anti-Bacterial Agents, Aminoglycosides, RNA, Ribosomal, 16S, Drug Resistance, Bacterial, Humans, Proteus Infections, Proteus mirabilis
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).17 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!